Skip to main content

Concierge nuclear imaging · London

Amyloid imaging, PET-CT and DPD scans for cardiac and cerebral amyloidosis.

Amyloid imaging includes cerebral amyloid PET (florbetaben / florbetapir / flutemetamol) for Alzheimer’s disease and Tc-99m DPD / PYP SPECT for transthyretin cardiac amyloidosis (ATTR). Modern, non-invasive diagnostic pathway.

See indicative pricing
A nuclear medicine consultant preparing an amyloid PET-CT scan in a private London clinic

Why patients choose us

  • 01

    The right hands

    We route you to a consultant nuclear medicine physician — with amyloid imaging experience, who reads the scan decides the answer.

  • 02

    Memory and cardiology pathways

    Cerebral amyloid PET or cardiac DPD / PYP — routed into the right memory-clinic or cardiology MDT once reported.

  • 03

    Independent, and free

    We are paid by no clinic, so the recommendation is impartial and costs you nothing.

Indicative pricing

What a private amyloid scan costs in London.

Indicative ranges across our partner clinics. Send the details and we quote firm figures across two or three options.

In short

Cerebral amyloid PET in our network: £2,400–£3,600. Cardiac DPD / PYP: £1,400–£2,200.

Scan type Indicative range
Cerebral amyloid PET-CT (florbetaben / florbetapir / flutemetamol) £2,400–£3,600
Cardiac Tc-99m DPD / PYP SPECT (ATTR imaging) £1,400–£2,200
Amyloid PET + memory-clinic consultation £3,200–£4,600
Cardiac amyloid work-up (DPD + bloods + light chains) £1,800–£2,800
Repeat amyloid PET (therapy monitoring) £2,400–£3,600
Urgent same-week amyloid scan £2,600–£4,000

Prices vary by clinic, whether the scan is cerebral or cardiac, and whether a same-visit memory-clinic or cardiology consultation is included. We come back with a firm quote within one working day.

The problem

An amyloid scan is only as good as who reads it.

Amyloid PET and DPD imaging are the answer only when read by a nuclear medicine consultant with amyloid experience and folded into the right memory or cardiology MDT. We route you to that consultant, not a generalist.

  • Memory concerns or MCI?

    We arrange a cerebral amyloid PET and route findings to a memory-clinic MDT.

  • Suspected cardiac ATTR?

    We arrange Tc-99m DPD / PYP with the AL exclusion bloods and cardiology follow-up.

  • Familial ATTR mutation?

    We co-ordinate cascade DPD imaging and genetic counselling for the wider family.

The journey

From enquiry to report — what happens, in order.

One clinician-led pathway from first message to report — often within a week.

  1. 01

    Before

    You tell us what’s going on

    A short, confidential form. Symptoms, memory or cardiac concerns, referral or insurer if you have them.

  2. 02

    Before

    We come back with a recommendation

    Within one working day: whether an amyloid scan is the right test, which clinic, indicative price. If a scan isn’t the right step, we say so.

  3. 03

    Before

    Consultant referral arranged

    Amyloid imaging requires a memory-clinic or cardiology consultant request — we co-ordinate this end-to-end.

  4. 04

    On the day

    Arrival and preparation

    Fasting is not required for most protocols. Bring a list of medications and prior imaging.

  5. 05

    On the day

    IV tracer and uptake wait

    A small intravenous dose of florbetaben, florbetapir, flutemetamol or Tc-99m DPD / PYP, followed by a 20–90 minute uptake wait.

  6. 06

    On the day

    PET-CT or SPECT acquisition

    20–40 minutes on the scanner — painless, quiet, still.

  7. 07

    After

    Report and next steps

    Nuclear medicine consultant report, then result feedback in memory or cardiology clinic with a concrete onward plan.

Typical end-to-end: 7–10 days. Urgent cases: same week.

What it shows

When an amyloid scan is the right test.

Amyloid imaging answers a specific question — is there β-amyloid in the brain, or transthyretin amyloid in the heart, and what does that mean for diagnosis and treatment.

  • Cerebral β-amyloid burden

    Quantifies fibrillar β-amyloid plaque load across the cortex.

  • Regional cortical amyloid pattern

    Frontal, parietal, temporal and precuneus distribution — the typical Alzheimer’s signature.

  • Cardiac ATTR uptake (Perugini grade)

    Grade 0–3 myocardial uptake on DPD / PYP — Grade 2–3 is diagnostic for ATTR.

  • Distinguish ATTR from AL amyloidosis

    DPD / PYP is specific for ATTR; positive light chains still need biopsy to exclude AL.

  • Reassure a normal amyloid PET

    A negative cerebral amyloid PET makes Alzheimer’s pathology very unlikely.

  • Follow disease progression

    Serial imaging tracks plaque burden or myocardial uptake over time.

  • Response to disease-modifying therapy

    Monitors amyloid clearance with lecanemab, donanemab or ATTR-directed treatment.

  • Red flag: heavy cardiac ATTR uptake with heart failure — urgent tafamidis / patisiran pathway

    Grade 2–3 DPD uptake plus NYHA III-IV symptoms is a same-week cardiology referral.

Scan types

Not all amyloid scans are the same.

What each option on your referral is actually for.

  • Cerebral amyloid PET-CT

    Florbetaben, florbetapir or flutemetamol PET — the standard imaging biomarker for cortical β-amyloid.

  • Cardiac DPD / PYP SPECT

    Tc-99m bone-avid tracer — highly specific for transthyretin (ATTR) cardiac amyloidosis.

  • Amyloid PET + memory consult

    Scan plus a same-visit consultant memory-clinic opinion, with a plan you can act on.

  • Cardiac amyloid work-up

    DPD imaging alongside serum free light chains and cardiac biomarkers — full ATTR / AL differentiation.

  • Therapy-monitoring amyloid PET

    Serial cerebral PET to track response to anti-amyloid antibody therapy.

  • Pre-treatment ATTR staging

    DPD imaging with echo and cardiac MRI to stage ATTR before tafamidis or patisiran.

  • Familial ATTR screening

    Cascade DPD imaging in relatives of confirmed familial ATTR mutation carriers.

  • Urgent same-week amyloid scan

    Expedited slot when heart-failure or rapid cognitive decline demand a rapid answer.

Our vetted London network

A small panel of clinics, we picked them.

Nuclear medicine partners across central London. Not listed publicly — introductions are made privately, once we understand your case.

Selection criteria

How we choose every clinic in our network.

A modern London nuclear medicine suite with a current-generation PET-CT scanner
Consultant nuclear medicine
  • Consultant nuclear medicine physicians with amyloid imaging experience

  • Standardised appropriate-use criteria (Alzheimer’s Association / EANM)

  • Formal report within 3–5 days, with images available for onward review

  • Onward memory-clinic or cardiology-MDT pathway once the scan is reported

Safety and eligibility

A well-established, low-dose imaging pathway.

Amyloid PET and DPD imaging use small radiotracer doses in line with EANM guidance. The practical points are when a private slot is right and when urgent NHS care is right, and where the scan’s limits are.

  • Low-dose radiation

    Amyloid PET and Tc-99m DPD both use small, well-characterised radiotracer doses in line with EANM guidance.

  • IV cannula for tracer

    A single intravenous injection of tracer — no oral contrast, no MRI contrast.

  • Uptake wait, then scanning

    You wait 20–90 minutes in a quiet room while the tracer distributes, then a 20–40 minute scan.

  • No fasting for most protocols

    Eat, drink and take medication as normal unless the clinic specifies otherwise.

  • Rapid cognitive decline is urgent

    Sudden or rapidly progressive memory change needs same-week neurology, not a routine private slot.

  • ATTR with heart failure is urgent

    Grade 2–3 DPD uptake with NYHA III-IV symptoms is a same-week cardiology referral for tafamidis pathway.

  • A normal amyloid PET is reassuring

    A negative cerebral amyloid PET makes Alzheimer’s pathology very unlikely, though other dementias remain possible.

  • AL amyloidosis needs biopsy

    DPD is specific for ATTR — positive serum light chains still require tissue biopsy to confirm or exclude AL.

  • Bring prior imaging and biomarkers

    MRI brain, echo, cardiac MRI, serum light chains and cardiac biomarkers materially sharpen the report.

Reading your report

An amyloid scan report can look intimidating. It isn’t.

Whatever the finding, the report keeps to the same four parts.

A consultant nuclear medicine physician reviewing amyloid PET images on a clinical workstation at a UK private clinic

A quiet reminder

The report is written for your doctor, not for you — and that’s normal.

If you would like us to talk you through it before your follow-up, just ask.

  1. 01 Header

    Indication and clinical context

    Your details, the reason for the scan, and the memory or cardiac history that shapes interpretation.

  2. 02 Technique

    Tracer, dose and acquisition

    Which tracer (florbetaben / florbetapir / flutemetamol / DPD / PYP), the administered activity, and the acquisition protocol.

  3. 03 Findings

    Regional uptake and Perugini grade

    Cortical amyloid distribution or myocardial Perugini grade, with visual and (where used) quantitative assessment.

  4. 04 Impression

    The conclusion: read this first

    Positive / negative amyloid PET, or Perugini grade with ATTR probability, and the concrete next step — read this first.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Cover depends on your policy and clinic; we confirm with your insurer before booking.

Frequently asked

Everything we get asked about amyloid imaging.

Quick answers on cost, referrals, amyloid PET vs DPD, and how the scan folds into an Alzheimer’s or ATTR diagnostic pathway.

  • What does an amyloid scan show?

    It shows abnormal amyloid protein deposition — either fibrillar β-amyloid plaques in the brain (with amyloid PET for suspected Alzheimer’s disease) or transthyretin amyloid in the heart muscle (with Tc-99m DPD or PYP SPECT for suspected cardiac ATTR amyloidosis).

  • What is the difference between amyloid PET and a DPD scan?

    Amyloid PET uses florbetaben, florbetapir or flutemetamol to image β-amyloid in the brain. Tc-99m DPD / PYP SPECT uses a bone-avid tracer that binds cardiac transthyretin amyloid — it is the imaging test of choice for ATTR cardiomyopathy, and Grade 2–3 uptake is diagnostic.

  • How much does a private amyloid scan cost in London?

    Cerebral amyloid PET-CT is typically £2,400–£3,600 in our network. Cardiac DPD / PYP SPECT is typically £1,400–£2,200. Adding a memory-clinic or cardiology consultation raises the price. We confirm a firm figure within one working day.

  • Do I need a referral?

    Yes. Amyloid imaging requires a memory-clinic or cardiology consultant request — it is not a self-referral scan. We arrange the consultant referral as part of the pathway.

  • Can amyloid PET diagnose Alzheimer’s disease on its own?

    A positive amyloid PET is a strong biomarker for Alzheimer’s pathology, but the diagnosis is made in a memory clinic using clinical assessment, cognitive testing, MRI and (where indicated) CSF or plasma biomarkers alongside the scan.

  • How quickly will I get results?

    A formal nuclear medicine consultant report is typically issued within 3–5 working days, with result feedback in memory or cardiology clinic once the report is available.

WhatsApp Call us

In practice, in London

Booking amyloid scan privately in London — what actually happens

With amyloid scan, the London question is usually about report turnaround and the radiologist reading it — not whether the scan is available. Public provision for amyloid scan is competent but constrained by capacity. Private London clinics tend to have shorter diaries and longer appointment slots, so you get the same specialists with more time. For people who’ve been going round in circles with primary care, that first proper conversation is often what shifts things.

A typical private booking for amyloid scan in London starts with a consultant conversation — sometimes in person on Harley Street or Marylebone, sometimes on video if that suits better. Any imaging or diagnostics happen at a nearby CQC-registered facility, and reports usually land within 24 to 72 hours. The whole loop, from first call to written report, is often done inside a fortnight. For amyloid scan specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.

Fit matters more than people expect. For amyloid scan, the right consultant depends on what you actually need — a second opinion, a definitive diagnosis, a bridge into treatment, or reassurance that nothing’s being missed. We match on that, not on who has the biggest brochure. If a test isn’t the right next step, we’ll say so before you book anything.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

Confidential. We respond within one working day.